Preparation Tafinlar from cancer treatment of British pharmaceutical company GlaxoSmithKline had been sent to FDA with the sign "breakthrough therapy for lung cancer', meaning the drug will be fast-tracked within the
GSK said that Tafinlar, also known as dabrafenib, was designated an FDA breakthrough therapy on Monday following interim results from an ongoing Phase II study.
Tafinlar is already approved for melanoma, the deadliest form of skin cancer.
Scientists Identify Mechanism That Prevents the Immune System from Fighting Blood Disorders
Journal of Clinical Oncology: ‘Forever Chemicals’ Linked to Increased Risk of an Aggressive Form of Breast Cancer
Natural Compound Triptolide Makes Cancer Cells More Vulnerable to Treatment
Scientists Create Molecular Map of Breast Cancer, Uncovering Previously Unknown Tumor Subtypes
Nature Medicine: Cervical Cancer Deaths Projected to Rise by 39.3% by 2050
Study: Activating Mitochondria May Slow the Growth of Cancer Cells
make preferable